Not applicableStudy completedNCT04816630What this trial is testingFeasibility Study of Hematology Parameters in COVID-19 DiseaseWho this might be right forCovid19SepsisAdults+1 more Beckman Coulter, Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT07046078What this trial is testingCombination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid CancerWho this might be right forAcute Leukemia of Ambiguous LineageAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03386513What this trial is testingStudy of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCNWho this might be right forBlastic Plasmacytoid Dendritic Cell NeoplasmMyeloproliferative Neoplasm AbbVie 179
Large-scale testing (Phase 3)Not Yet RecruitingNCT07288489What this trial is testingPhase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.Who this might be right forBlood Loss, SurgicalCoagulation Disorder VarmX B.V. 800
Not applicableStudy completedNCT00014235What this trial is testingFludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more Fred Hutchinson Cancer Center 160
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT00949117What this trial is testingCyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With CancerWho this might be right forLeukemiaLymphomaMalnutrition+3 more University of South Florida 9
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Early research (Phase 1)Study completedNCT02185781What this trial is testingPhase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD) Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Early research (Phase 1)Ended earlyNCT04637009What this trial is testingTAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsWho this might be right forAcute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm Astex Pharmaceuticals, Inc. 20
Not applicableStudy completedNCT01431326What this trial is testingPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareWho this might be right forAdenovirusAnesthesiaAnxiety+56 more Daniel Benjamin 3,520
Post-approval studies (Phase 4)Study completedNCT00369772What this trial is testingSTAAR-1 Clinical StudyWho this might be right forChronic Kidney DiseaseChronic Renal InsufficiencyKidney Disease+2 more Amgen 2,000
Not applicableStudy completedNCT00716911What this trial is testingMeasuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00368901What this trial is testingSTAAR-2 Clinical StudyWho this might be right forChronic Kidney DiseaseChronic Renal InsufficiencyKidney Disease+2 more Amgen 618
Testing effectiveness (Phase 2)Study completedNCT00089011What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more Fred Hutchinson Cancer Center 150
Early research (Phase 1)Study completedNCT01456676What this trial is testingNilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior TherapyWho this might be right forPhiladelphia Chromosome Positive Chronic Myelogenous Leukemia Novartis Pharmaceuticals 11
Early research (Phase 1)WithdrawnNCT05176691What this trial is testingHMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHLWho this might be right forCLL/SLLNHLMCL+6 more Hutchmed
Not applicableEnded earlyNCT00813501What this trial is testingImmunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more City of Hope Medical Center 60
Not applicableStudy completedNCT00897767What this trial is testingCollecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialWho this might be right forLeukemiaLymphoma Eastern Cooperative Oncology Group 1,873
Not applicableLooking for participantsNCT01087333What this trial is testingCollection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer TreatmentWho this might be right forHairy Cell Leukemia (HCL)Chronic Lymphocytic Leukemia (CLL)Non-Hodgkins Lymphoma (NHL)+2 more National Cancer Institute (NCI) 1,263